Real-world effectiveness of Ad26.COV2.S or BNT162b2 booster vaccines against severe COVID-19 in adults who received a primary dose of Ad26.COV2.S in South Africa during the Delta period: A retrospective cohort study using medical scheme data - L Fairall; N Yende-Zuma; Tarylee Reddy; N Garrett; A Goga; S Bennet; N Folb; I Seocharan; S Mametja; M Semenya; S R N Simelane; L-G; et al. (South African Medical Journal)